Xiao Jie Liu
Director/Board Member chez YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.
Profil
Xiao Jie Liu is currently the Board Secretary, Director & Deputy General Manager at Yantai Dongcheng Biochemicals Co., Ltd.
since 2022.
He is also currently a Director at MITRO Biotech Co., Ltd.
since 2020.
Previously, he worked as an Accounting Manager at Yantai Dongcheng Biochemicals Co., Ltd.
Mr. Liu completed his undergraduate degree at Shandong University of Finance & Economics.
Postes actifs de Xiao Jie Liu
| Sociétés | Poste | Début |
|---|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Director/Board Member | 19/05/2022 |
Mitro Biotech Co., Ltd.
 Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Director/Board Member | 25/07/2020 |
Anciens postes connus de Xiao Jie Liu
| Sociétés | Poste | Fin |
|---|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Public Communications Contact | - |
Formation de Xiao Jie Liu
| Shandong University of Finance & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mitro Biotech Co., Ltd.
Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Commercial Services |
